SEARCH
Watch | USFDA rejects Bharat Biotech's Covaxin for emergency use, Is rejection a setback for company?
India Today
2021-06-12
Views
6
Description
Share / Embed
Download This Video
Report
The US Food and Drug Administration has refused to give emergency use authorisation to Bharat Biotech’s Covaxin. The USFDA has denied it because they say they don't have enough data yet to grant EUA.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x81wxjc" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:07
US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
01:49
Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News
04:11
No emergency use approval for Bharat Biotech's Covaxin in US, FDA seeks more info & data
01:51
Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources
09:12
Expert panel recommends Bharat BioTech's Covaxin for restricted emergency use
01:23
WHO expert panel to decide today on emergency use nod to Bharat Biotech’s Covaxin | Oneindia News
01:32
Bharat Biotech's Covaxin Approved for Emergency Vaccination for 8-12 Age Group
07:47
Bharat Biotech's Covaxin granted emergency use approval for kids aged 2-18 years
00:50
Bharat Biotech's Covaxin shows positive results
01:29
Covaxin, Bharat Biotech's Coronavirus Vaccine Cleared For Phase 3 Trials || Oneindia Telugu
03:28
Coronavirus vaccine update: Bharat Biotech's Covaxin to start human trial
00:32
Bharat Biotech's Covaxin shows promising results
